Clinical Trials Directory

Trials / Completed

CompletedNCT02737800

Effect of Prolonged GnRh Agonists on Results of Intracytoplasmic Sperm Injection (ICSI ) in Endometrioma Patients

Effect of Prolonged GnRh Agonist Therapy on the Outcome of In-Vitro Fertilization& Embryo Transfer in Endometrioma Patients

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
88 (actual)
Sponsor
Kasr El Aini Hospital · Academic / Other
Sex
Female
Age
18 Years – 40 Years
Healthy volunteers
Not accepted

Summary

Investigators compare ICSI results for endometrioma patients with or without cyst aspiration if more than 5cm \&with or without GnRh agonists for all endometrioma patients

Detailed description

Group 1 consists of 30 patients of endometrioma more than 5cm subdivided into: Group 1A;Cyst aspiration followed by standard long protocol in 15 patients Group 1B;Cyst aspiration followed by GnRh suppression for 3 months then standard long protocol in 15 patients Group 2 consists of 30 patients of endometrioma less than 5cm subdivided into : Group 2A;no intervention to the cyst. Standard long protocol Group 2B;GnRh suppression for 3 months then standard long protocol

Conditions

Interventions

TypeNameDescription
PROCEDUREendometrioma aspirationTransvaginal ultrasound guided aspiration
DRUGGnRh agonist ( Decapeptyl )3 monthly doses of Decapeptyl 7.5mg intramuscular
PROCEDUREstandard long stimulation protocolDecapeptyl 3.75mg in the mid luteal phase followed by human menopausal gonadotropins(HMG);fostimon, or merional injections after bleeding, doses are individualization according to each patient, monitored by follicular size \&serum estradiol.

Timeline

Start date
2016-04-01
Primary completion
2017-08-01
Completion
2017-08-01
First posted
2016-04-14
Last updated
2018-07-31

Locations

1 site across 1 country: Egypt

Source: ClinicalTrials.gov record NCT02737800. Inclusion in this directory is not an endorsement.